Home » Topics » Disease categories and therapies » Immune

Immune
RSS

First patient enrolled in phase II study of AR-201 for egg allergy

Aug. 22, 2019

Malaria vaccine has indirect protective effects

Aug. 21, 2019

Preclinical data presented for the novel re-engineered lupus autoantibody PAT-DX1

Aug. 20, 2019

First-in-human results for the chlamydia vaccine candidate CTH-522

Aug. 20, 2019

Pharmacokinetics and safety data presented from phase I study of EA-230

Aug. 16, 2019

Kezar Life Sciences initiates PRESIDIO and MARINA phase II studies of KZR-616

Aug. 14, 2019

First patient dosed in phase Ib/IIa PREVAIL study of PRV-3279

Aug. 9, 2019

Novel T-cell subtype predicts risk of anaphylactic shock

Aug. 8, 2019

Wild moms are good for offspring microbiome

Aug. 8, 2019

Dosing starts in phase I study of DNL-758

Aug. 6, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Asia
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Capital remains selective in ‘barbell’ biotech market
BioWorld Asia
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...